Prime Medicine, Inc. short interest in 2025
In 2025, Prime Medicine, Inc.'s disclosed short interest ran from 13.12% of shares outstanding on 15 Jan 2025 to 14.22% on 31 Dec 2025, a change of +1.10 percentage points. The year's high was 16.50% on 15 Jul 2025 and its low 10.09% on 31 Oct 2025, averaging 13.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.82 days on 31 Jan 2025. Full history: Prime Medicine, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 13.12% (15 Jan 2025)
- End of year
- 14.22% (31 Dec 2025)
- Change
- +1.10 pp
- High
- 16.50% (15 Jul 2025)
- Low
- 10.09% (31 Oct 2025)
- Average
- 13.48%
- Highest days to cover
- 23.82 (31 Jan 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 13.12% | 19.37 | |
| 31 Jan 2025 | 13.19% | 23.82 | |
| 14 Feb 2025 | 13.77% | 15.83 | |
| 28 Feb 2025 | 13.76% | 16.56 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 14.80% | 12.92 | |
| 31 Mar 2025 | 13.95% | 12.51 | |
| 15 Apr 2025 | 12.73% | 9.24 | |
| 30 Apr 2025 | 12.59% | 10.77 | |
| 15 May 2025 | 13.48% | 12.73 | 10-Q filed, results (8-K) |
| 30 May 2025 | 13.68% | 5.17 | |
| 13 Jun 2025 | 14.08% | 9.65 | |
| 30 Jun 2025 | 15.34% | 4.67 | |
| 15 Jul 2025 | 16.50% | 3.35 | |
| 31 Jul 2025 | 16.24% | 4.50 | results (8-K) |
| 15 Aug 2025 | 13.65% | 4.30 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.30% | 6.97 | |
| 15 Sep 2025 | 14.21% | 6.69 | |
| 30 Sep 2025 | 14.87% | 5.17 | |
| 15 Oct 2025 | 11.72% | 3.35 | |
| 31 Oct 2025 | 10.09% | 4.85 | |
| 14 Nov 2025 | 10.31% | 4.86 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.90% | 5.01 | |
| 15 Dec 2025 | 12.12% | 6.35 | |
| 31 Dec 2025 | 14.22% | 6.26 |
See also: Prime Medicine, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.